Articles Posted in Wellness studies

Published on:

Rheumatoid arthritis is a painful condition and many victims who suffer from this debilitating disease apply for Social Security disability benefits every year.

A person who suffers from rheumatoid arthritis may suffer from pain, severe inflammation, and stiffness in the joints combined with excessive fatigue. There are also several complications associated with rheumatoid arthritis, including osteoporosis, dry eyes, infections, carpal tunnel syndrome, and even cardiac disease. These complications make it extremely difficult for a person to work and earn a sustainable income.

A new study finds that eating more fish can help relieve some of the painful symptoms associated with rheumatoid arthritis. The results of the study were published recently in the journal Arthritis and Rheumatology. Researchers were specifically looking at how increasing fish consumption could reduce activity of the disease.

Published on:

Research shows that stem cell therapy has many benefits for arthritis patients, especially those who suffer from advanced stages of the condition.

According to ongoing studies, stem cell therapy may not promise a complete cure for arthritis, but could trigger the production of healthy cells that can replace damaged cells. These stem cell transplants are now being used to replace damaged cartilage between joints.

Arthritis is a condition involving inflammation of the joints, swelling and pain. Over time, joints can become weak, and the pain chronic. There are several types of arthritis, the most common being osteoarthritis and rheumatoid arthritis. The Centers for Disease Control and Prevention estimates that more than 50 million Americans have been diagnosed with some form of arthritis.

Published on:

The upcoming trials of an inexpensive drug that is already used to lower high cholesterol levels will be watched closely by doctors as well as patients who suffer from Multiple Sclerosis (MS).

In 2014, trials found that MS patients who were administered Simvastatin showed significant reductions in brain atrophy levels, compared to those who were not given the drug. That was a smaller trial with just 140 participants, but a new larger trial that is due to begin soon will focus on more than 1,100 people, and will try to confirm the results of the earlier study.

The new study will specifically look at whether the administration of Simvastatin helps reduce the progression of MS in patients. Researchers are optimistic that the drug holds plenty of potential for millions of Multiple Sclerosis sufferers in the United Kingdom – where the trial will be conducted – and around the world.

Published on:

Scientists recently announced that they have discovered a gene that is responsible for a condition that causes children to be born with blindness, deafness, and other serious symptoms.

This condition is known as COMMAD Syndrome, and children born with it suffer from deafness, blindness, albinism, fragile bones, a large head, malformed eyes, and prematurely graying hair. According to scientists, the condition is caused when children inherit a gene mutation called MITF from parents who are deaf and suffer from another genetic disorder called Waardenburg Syndrome 2A.

Not every person who suffers from deafness also suffers from Waardenburg Syndrome 2A. In fact, most people do not suffer from this rare genetic disorder. However, deaf persons often prefer to marry other deaf persons, and according to the researchers, it is important for persons to undergo genetic counseling before they get married to confirm that both of them do not suffer from Waardenburg Syndrome 2A. If they do, they may be at risk of transmitting the MITF genetic mutation to their children.

Published on:

Stroke treatments in the future could be significantly better than they are now, thanks to research that has found a new way to safely remove clots in patients.

Doctors currently treat stroke by using an infusion which removes the blood clots by dissolving them. However, patients who are given this treatment stand a risk of swelling in the brain and excessive bleeding.  In addition, patients must receive the infusion within three hours of suffering the stroke for the treatment to be effective.

However, researchers at the Joslin Diabetes Center in Boston are using a drug combination that will potentially improve outcomes for stroke patients. The researchers conducted tests on mice, and found that when the mice were given the new treatment, there was a drop in bleeding levels, lowered swelling in the brain, and limited brain damage, compared to animals that were not given the treatment.

Published on:

While the fatality rate from cardiac disease is on its way down across the United States, the rates of heart failure are increasing. That information comes from a new report by the American Heart Association, which also finds that cardiac disease is still the leading cause of death in the United States.

According to the report, over a period of just five years, the number of Americans who suffer from heart failure increased by 800,000. In fact, according to the American Heart Association (AMA), over the next few years, that rate is expected to increase further. By 2030, the rate of heart failure in the US is expected to increase by a staggering 46%. Approximately 8,000,000 people by that time will suffer from some degree of heart failure. At special risk are seniors and survivors of heart attacks, who constitute the most at-risk groups for heart failure.

A person who suffers from heart failure will typically encounter a number of complications that severely impact his or her health. For instance, heart failure increases the risk of blood leaking into other organs, including the liver and lungs. Persons, who suffer from heart failure may also experience shortness of breath, frequent swelling of the extremities, accelerated heart rate, confusion, disorientation, severe cough, and accumulation of body fluids. Furthermore, symptoms of heart failure tend to worsen over time.

Published on:

Scientists have welcome news for the more than 2.3 million people across the globe who live with multiple sclerosis. According to researchers, a new breakthrough drug can help reduce symptoms, and delay progression of this painful and debilitating disease, even in people who do not respond to any other treatments.

The new drug is expected to be approved by the Food and Drug Administration (FDA) as early as March. The drug called OCREVUS has been found to significantly delay the progression of symptoms of the disease, and limit the extent of physical disability in people who suffer from primary progressive multiple sclerosis. The drug reduces the frequency of attacks in these people.

MS can be a difficult condition to treat, because it affects different people in different ways. The severity of symptoms may differ between two different people, and the rate of progression may also vary. Many people with multiple sclerosis respond to some of the treatment drugs that are available on the market. These drugs are designed to limit symptoms, limit the progression of the disease, and reduce the number of attacks.

Published on:

A recent study by leading researchers has found a potential connection between gum disease and rheumatoid arthritis.

Beautiful, healthy gums mean not just a perfect smile, but could also mean healthier joints for you. Those findings came from a study that was published recently in the journal, Science Translational Medicine.  Researchers from some of the best institutions in the United States, including Johns Hopkins University School of Medicine, examined the gum fluid of people who suffer from periodontitis or gum disease, and found that the fluid contained high levels of a protein, which can trigger symptoms in people who suffer from rheumatoid arthritis.

The findings of the study are far from conclusive. The researchers have no evidence to confirm that everybody who suffers from gum disease is at a high risk of suffering from rheumatoid arthritis, or that everyone who suffers from arthritis, will have the specific immune response to the protein found in the gum fluid. In spite of this, however, it’s good advice to keep your gums healthy.  Pay attention to oral hygiene, because other studies have also linked gum disease to a number of other conditions, including diabetes and stroke.

Published on:

Persons who suffer from fibromyalgia and also have low levels of vitamin D in their bodies could suffer from balance and posture problems.

Those are the findings of a new study published in the journal, Modern Hematology. Patients with fibromyalgia often suffer from an increased risk of falls.  Researchers found in their study that vitamin deficiency is linked to a higher risk of such balance issues in patients.

This is not the first study to show these findings.  Researchers have long believed that lack of vitamin D leads to muscle weakness and deficient mineralization in the bones, which contributes to a high risk of fall accidents. Researchers say that vitamin D deficiency could negatively affect a person’s balance and also the intensity of pain levels that suffer from fibromyalgia.

Published on:

A scientific study published three years ago that claimed to have found breakthrough results in the search for a cure for diabetes has now been retracted.

The article titled Betatrophin: A Hormone that Controls Pancreatic Cell Proliferation was widely acclaimed when it was published back in 2013. According to researchers at that time, they had identified a new hormone that could help boost the secretion of insulin in diabetes patients, thereby making it unnecessary for patients to take insulin injections.

However, the group has now admitted that since then, research from another group has failed to replicate the findings of the earlier study. The earlier study had been conducted on rodents.  Now, the researchers have voluntarily retracted their 2013 study, and have confirmed that their earlier conclusion was wrong.